Move to get people fitter to fight the disease and withstand the side effects of treatment could save the NHS millions ...

A quarter of GPs strongly support the NHS introducing prostate cancer screening, but many highlight issues with PSA tests, a ...

US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...

NHS Cancer 360 tool aims to bring together data on cancer patients in one place, allowing clinicians access to all the information through the Federated Data Platform (FDP).

Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course ...

Two new advanced predictive algorithms use information about a person's health conditions and simple blood tests to accurately predict a patient's chances of having a currently undiagnosed cancer, ...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care ...

and our new Cancer 360 solution harnesses data to ensure exactly that. By giving clinicians a comprehensive view of patient pathways, we can identify and address delays immediately. “The NHS ...

The study, led by researchers in Sweden, found that delivering precision radiotherapy over just two and a half weeks is equally successful in beating prostate cancer as the standard eight-week ...

The NHS paid out £376,478,329 in damages and legal ... £23million was given to 100 claimants for cases involving advanced cancer. Bladder damage, never damage, stroke, amputation, spinal damage ...

“By giving clinicians a comprehensive view of patient pathways, we can identify and address delays immediately. “The NHS federated data platform (FDP) is already showing its value in transforming ...